Notice Number: NOT-FD-14-010
Key Dates
Release Date: May 20, 2014
Issued by
Food and Drug Administration (FDA)
Purpose
This Notice of Change is to inform potential applicants of changes to the published RFA-FD-14-016 "Evaluation of in Vitro Release Methods for Liposomal Drug Products (U01)" as indicated below:
Key Dates are changed as follows: The Application Due Date is extended to June 15, 2014, by 5:00 PM local time of applicant organization. Expiration Date has changed to June 16, 2014.
Section II. Award Information is changed as follows:
Funds Available and Anticipated Number of Awards: The FDA and partner components intend to commit $500,000 per award. Awards are contingent upon the availability of funds. Future year amounts will depend on annual appropriations and performance.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 2 year.
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Nan Zheng
Food and Drug Administration (FDA)
Telephone: 240-402-7972
Email: Nan.Zheng@fda.hhs.gov